Rehab Abdelmonem

1.1k total citations · 1 hit paper
46 papers, 831 citations indexed

About

Rehab Abdelmonem is a scholar working on Pharmaceutical Science, Molecular Biology and Dermatology. According to data from OpenAlex, Rehab Abdelmonem has authored 46 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pharmaceutical Science, 6 papers in Molecular Biology and 6 papers in Dermatology. Recurrent topics in Rehab Abdelmonem's work include Advanced Drug Delivery Systems (19 papers), Drug Solubulity and Delivery Systems (14 papers) and Advancements in Transdermal Drug Delivery (12 papers). Rehab Abdelmonem is often cited by papers focused on Advanced Drug Delivery Systems (19 papers), Drug Solubulity and Delivery Systems (14 papers) and Advancements in Transdermal Drug Delivery (12 papers). Rehab Abdelmonem collaborates with scholars based in Egypt, Saudi Arabia and United States. Rehab Abdelmonem's co-authors include Mohamed A. El-Nabarawi, Doaa H. Hassan, Kamel R. Shoueir, Mahmoud H. Teaima, Mohamed Nayel, Mohamed M. Taher, Rehan M. El-Shabasy, Sammar Fathy Elhabal, Hanan Refai and Menna M. Abdellatif and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and International Journal of Biological Macromolecules.

In The Last Decade

Rehab Abdelmonem

40 papers receiving 821 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic

2022 167 citations Rehab Abdelmonem, Kamel R. Shoueir et al. International Journal of Biological Macromolecules profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rehab Abdelmonem Egypt	17	349	132	125	99	74	46	831
Deepak Pradhan India	16	260 0.7×	170 1.3×	183 1.5×	84 0.8×	116 1.6×	78	1.0k
Mohammed Asadullah Jahangir India	12	273 0.8×	195 1.5×	127 1.0×	44 0.4×	40 0.5×	21	644
Mutasem Rawas‐Qalaji United Arab Emirates	17	248 0.7×	158 1.2×	130 1.0×	39 0.4×	47 0.6×	47	902
Punna Rao Ravi India	20	650 1.9×	244 1.8×	201 1.6×	88 0.9×	81 1.1×	57	1.1k
Carlos Bregni Argentina	16	217 0.6×	143 1.1×	114 0.9×	65 0.7×	70 0.9×	61	853
Bwalya A. Witika South Africa	18	295 0.8×	199 1.5×	180 1.4×	64 0.6×	28 0.4×	48	902
Rute Nunes Portugal	17	343 1.0×	190 1.4×	206 1.6×	169 1.7×	69 0.9×	32	947
Kunlun Wang China	13	162 0.5×	129 1.0×	142 1.1×	101 1.0×	136 1.8×	24	887
Veintramuthu Sankar India	14	373 1.1×	134 1.0×	125 1.0×	20 0.2×	37 0.5×	49	699
Doaa Ahmed El-Setouhy Egypt	16	559 1.6×	99 0.8×	78 0.6×	20 0.2×	76 1.0×	30	755

Countries citing papers authored by Rehab Abdelmonem

Since Specialization

Citations

This map shows the geographic impact of Rehab Abdelmonem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rehab Abdelmonem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rehab Abdelmonem more than expected).

Fields of papers citing papers by Rehab Abdelmonem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rehab Abdelmonem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rehab Abdelmonem. The network helps show where Rehab Abdelmonem may publish in the future.

Co-authorship network of co-authors of Rehab Abdelmonem

This figure shows the co-authorship network connecting the top 25 collaborators of Rehab Abdelmonem. A scholar is included among the top collaborators of Rehab Abdelmonem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rehab Abdelmonem. Rehab Abdelmonem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdelmonem, Rehab, et al.. (2025). Topical loratadine-loaded invasomal gel repurposed for vulvovaginal candidiasis; in vitro, in silico, ex vivo, and in vivo studies. International Journal of Pharmaceutics. 677. 125639–125639. 1 indexed citations

Albash, Rofida, et al.. (2025). Electrospun Nanofiber-Scaffold-Loaded Levocetirizine Dihydrochloride Cerosomes for Combined Management of Atopic Dermatitis and Methicillin-Resistant Staphylococcus Aureus (MRSA) Skin Infection: In Vitro and In Vivo Studies. Pharmaceuticals. 18(5). 633–633. 3 indexed citations

Abdelmonem, Rehab, et al.. (2025). Tailored Therapeutic Strategies for Fetuses, Neonates, Pediatrics, Geriatrics, Athletes, and Critical Cases in the Era of Personalized Medicine. Diseases. 14(1). 12–12.

Arneth, Borros, et al.. (2025). Optimized Hesperidin-Loaded Lipid Nanoparticles with Tea Tree Oil for Enhanced Wound Healing: Formulation, Characterization, and Evaluation. Pharmaceuticals. 18(3). 290–290. 9 indexed citations

Abdellatif, Menna M., et al.. (2025). Invasomes and Nanostructured Lipid Carriers for Targeted Delivery of Ceftazidime Combined with N-Acetylcysteine: A Novel Approach to Treat Pseudomonas aeruginosa-Induced Keratitis. Pharmaceutics. 17(9). 1184–1184.

Abdelmonem, Rehab, et al.. (2025). Anticariogenic efficacy of Indian Costus mouthwash in children. Journal of Herbal Medicine. 50. 100997–100997. 1 indexed citations

Fouad, Shahinaze A., et al.. (2025). Engineering orally disintegrating tablets for buccal delivery of cilostazol with enhanced dissolution and bioavailability: a novel dual porogenic approach, in vitro characterization, and in vivo evaluation in rats. Pharmaceutical Development and Technology. 30(3). 280–294.

Elhabal, Sammar Fathy, Rehab Abdelmonem, Rasha M. El Nashar, et al.. (2024). Enhanced Antibacterial Activity of Clindamycin Using Molecularly Imprinted Polymer Nanoparticles Loaded with Polyurethane Nanofibrous Scaffolds for the Treatment of Acne Vulgaris. Pharmaceutics. 16(7). 947–947. 23 indexed citations

Sharaky, Marwa, et al.. (2024). Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells. Archiv der Pharmazie. 357(10). e2400261–e2400261. 7 indexed citations

10.

Teaima, Mahmoud H., et al.. (2023). Topical delivery of extracted curcumin as curcumin loaded spanlastics anti-aging gel: Optimization using experimental design and ex-vivo evaluation. Saudi Pharmaceutical Journal. 32(1). 101912–101912. 11 indexed citations

11.

Teaima, Mahmoud H., et al.. (2023). Potential application of sucrose acetate isobutyrate, and glyceryl monooleate for nanonization and bioavailability enhancement of rivaroxaban tablets. SHILAP Revista de lepidopterología. 2. 100015–100015. 21 indexed citations

12.

Teaima, Mahmoud H., et al.. (2023). Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A Pharmacokinetics Study on Rats. Pharmaceuticals. 16(2). 326–326. 9 indexed citations

13.

Teaima, Mahmoud H., et al.. (2023). Sucrose acetate isobutyrate (SAIB) and glyceryl monooleate (GMO) hybrid nanoparticles for bioavailability enhancement of rivaroxaban: an optimization study. Pharmaceutical Development and Technology. 28(10). 928–938. 21 indexed citations

14.

Teaima, Mahmoud H., et al.. (2022). COMPREHENSIVE OVERVIEW ON RECENT UPDATES OF GASTRORETENTIVE RAFT-FORMING SYSTEMS. International Journal of Applied Pharmaceutics. 40–48. 7 indexed citations

15.

Abdou, Ebtsam M., et al.. (2022). Targeting Colorectal Cancer Cells with Niosomes Systems Loaded with Two Anticancer Drugs Models; Comparative In Vitro and Anticancer Studies. Pharmaceuticals. 15(7). 816–816. 34 indexed citations

16.

Teaima, Mahmoud H., et al.. (2021). Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats. Drug Design Development and Therapy. Volume 15. 4603–4614. 17 indexed citations

17.

Othman, Sarah I., Asma M. Alturki, Gasem Mohammad Abu-Taweel, et al.. (2021). Chitosan for biomedical applications, promising antidiabetic drug delivery system, and new diabetes mellitus treatment based on stem cell. International Journal of Biological Macromolecules. 190. 417–432. 38 indexed citations

18.

Abdelmonem, Rehab, et al.. (2020). OCULAR DELIVERY OF NATAMYCIN SOLID LIPID NANOPARTICLE LOADED MUCOADHESIVE GEL: FORMULATION, CHARACTERIZATION AND IN VIVO STUDY. International Journal of Applied Pharmaceutics. 173–180. 7 indexed citations

19.

Abdelbar, Mostafa F., et al.. (2020). Highly ordered functionalized mesoporous silicate nanoparticles reinforced poly (lactic acid) gatekeeper surface for infection treatment. International Journal of Biological Macromolecules. 156. 858–868. 40 indexed citations

20.

Abdelmonem, Rehab, et al.. (2020). <p>Formulation and Characterization of Cinnarizine Targeted Aural Transfersomal Gel for Vertigo Treatment: A Pharmacokinetic Study on Rabbits</p>. International Journal of Nanomedicine. Volume 15. 6211–6223. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact